Skip to main content
Log in

Human atrial natriuretic peptide in patients with type 1 diabetes mellitus: is it related to the development of diabetic nephropathy?

  • Original Article
  • Published:
The clinical investigator Aims and scope Submit manuscript

Summary

There is controversy as to whether increased plasma levels of human atrial natriuretic peptide (hANP) in patients with type 1 diabetes mellitus may contribute to the development of diabetic nephropathy. Therefore, we decided to conduct two studies to examine the relationship of hANP levels to urinary albumin excretion and blood pressure. In a cross-sectional study, 83 randomly selected type 1 diabetic patients were investigated. 19 of the patients had increased urinary albumin excretion. 45 healthy volunteers served as controls. In a longitudinal study, 19 type 1 diabetic patients were examined for one year at monthly intervals. An increased risk of eventually developing diabetic nephropathy was identified in 7 out of these patients by repeatedly revealing increased urinary albumin excretion. On the average, hANP levels were increased in type 1 diabetic patients in comparison to controls (P < 0.001). In both studies, hANP levels were positively related (P < 0.05) to mean arterial blood pressure. There was no correlation between hANP levels and metabolic control. hANP levels lay within normal range irrespective of normal or elevated urinary albumin excretion provided that mean arterial blood pressure was normal. In the longitudinal study, increased urinary albumin and alpha-1-microglobulin excretion preceded the increase in both hANP levels and mean arterial blood pressure. Although hANP levels were evidently not related to the disease mechanisms of early diabetic nephropathy, it is tempting to speculate that hANP may contribute to the vicious circle connecting diabetic kidney disease to hypertension once that its levels are increased by elevated blood pressure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

hANP:

human atrial natriuretic peptide

References

  1. Allen TJ, Cooper ME, O'Brien C, Bach LA, Jackson B, Jerums G (1990) Glomerular filtration rate in streptozocininduced diabetic rats. Diabetes 39:1182–1190

    Google Scholar 

  2. Anderson S (1992) Pathogenesis of diabetic nephropathy: hemodynamic factors. Contemp Issues Nephrol 20:67–85

    Google Scholar 

  3. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T (1983) Diabetic nephropathy in type 1 (insulindependent) diabetes: an epidemiological study. Diabetologia 25:496–501

    CAS  PubMed  Google Scholar 

  4. Barnett AH, Pyke DA (1992) The genetics of diabetic complications. Clin Endocrinol Metab 15:715–726

    Google Scholar 

  5. Barzilay J, Warram JH, Bak M, Laffel LMB, Canessa M, Krolewski AS (1992) Predisposition to hypertension: risk factor for nephropathy and hypertension in IDDM. Kidney Int 41:723–730

    Google Scholar 

  6. Borch-Johnsen K, Norgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T, Parving HH (1992) Is diabetic nephropathy an inherited complication? Kidney Int 41:719–722

    Google Scholar 

  7. Cuneo RC, Espiner EA, Crozier IG, Yandel TG, Nicholls MG, Ikram H (1989) Chronic and acute volume expansion in normal man: effect on atrial diameter and plasma atrial natriuretic peptide. Horm Metab Res 21:148–151

    Google Scholar 

  8. Dahl-Jorgensen K, Bjoro T, Kierulf P, Sandvik L, Bangstad HJ, Hanssen KF (1992) Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus. Kidney Int 41:920–923

    Google Scholar 

  9. Dussaule JC, Grimaldi A, Czekalski S, Coutarel P, Bosquet F, Ardaillou R (1988) Atrial natriuretic peptide in diabetic patients with microangiopathy. Horm Metab Res 20:592–594

    Google Scholar 

  10. Dussaule JC, Ardaillou R (1990) Current indications of plasma atrial natriuretic peptide measurements in human disease. Horm Res 34:133–137

    Google Scholar 

  11. Genest J, Larochelle P, Cusson RR, Cantin M (1989) The atrial natriuretic peptide in hypertension. In: Kaufmann W, Wambach G (eds) Endocrinology of the heart. Springer, Berlin Heidelberg New York, pp 90–98

    Google Scholar 

  12. Giorato C, Fioretto P, Trevisan R, Morocutti A, DeDona C, Dorella M, Abruzzese E, Botta GF, Iori E, Nosadinin R (1989) Captopril treatment normalizes baseline atrial natriuretic peptide levels and ANP response to isotonic volume expansion in hypertensive type 1 diabetic patients. Diabetologia 32:492A

    Google Scholar 

  13. Haak T, Jungmann E, Felber A, Hillmann U, Usadel KH (1992) Increased plasma levels of endothelin in diabetic patients with hypertension. Am J Hypertens 5:161–166

    Google Scholar 

  14. Hartter E, Woloszczuk W, Summvoll HK (1986) Radio-immunoassay of atrial natriuretic peptides in human plasma. Clin Chem 32:441–445

    Google Scholar 

  15. Hartter E, Woloszczuk W (1989) Radioimmunoassay of endothelin. Lancet 333:909

    Google Scholar 

  16. Ishii M, Hirata Y, Sugimoto T, Matsuoko H, Kimura K, Ishimitsu T, Fukui K, Sugimoto T, Kurosawa Y, Kiyose H, Kangawa K, Matsuo H (1989) Effect of human atrial natriuretic peptide on proteinuria in patients with glomerular diseases. Clin Sci 77:643–650

    Google Scholar 

  17. Jungmann E, Höll E, Koncok C, Fassbinder W, Schöffling K (1988) Welchen pathophysiologischen Stellenwert haben erhöhte Plasmaspiegel des humanen atrialen natriuretischen Peptides bei Patienten mit Diabetes mellitus? Z Kardiol 77 [Suppl 2]:114–118

    Google Scholar 

  18. Jungmann E, Seel K, Hofmann E, Scheuermann EH, Schöffling K (1989) Effects of nifedipine on renal responses to human atrial natriuretic peptide in healthy subjects and normoglycemic patients with type 1 diabetes mellitus. Klin Wochenschr 67:1174–1181

    Google Scholar 

  19. Jungmann E, Usadel KH (1991) Effect of captopril on renal functional reserve in type 1 diabetes mellitus. Diabetologia 34:843–844

    Google Scholar 

  20. Jungmann E, Galette A, Hopfenmüller B, Palitzsch KD, Scherberich J, Usadel KH (1992) Einflu\ der Stoffwechseleinstellung auf renale Wirkungen des humanen atrialen natriuretischen Peptides-(95–126) (Urodilatin) bei normotensiven Patienten mit Typ-1-Diabetes mellitus. Med Klin 87:242–246

    Google Scholar 

  21. Jungmann E, Schumm-Draeger PM, Scheuermann EH, Usadel KH (1992) Antihypertensive Langzeittherapie von Diabetespatienten mit Felodipin. Fortschr Med 110:224–226

    Google Scholar 

  22. Mathiesen ER, Ronn B, Jensen T, Storm B, Deckert T (1992) Relationship between blood pressure and urinary albumin excretion in development of microalbuminura. Diabetes 39:245–249

    Google Scholar 

  23. Neyses L, Nitsch J, Tüttenberg HP, Korus HC, Lüderitz B (1989) Erhöhtes atriales natriuretisches Peptid bei essentieller Hypertonie — Abhängigkeit vom rechtsatrialen Druck. Klin Wochenschr 67:756–763

    Google Scholar 

  24. Norgaard K, Storm B, Graae M, Feldt-Rasmussen B (1989) Elevated albumin excretion and retinal changes in children with type 1 diabetes mellitus are related to long-term poor blood glucose control. Diab Med 6:325–328

    Google Scholar 

  25. Ortola FV, Ballermann BJ, Anderson S, Mendez RE, Brenner BM (1987) Elevated plasma atrial natriuretic peptide levels in diabetic rats. J Clin Invest 80:670–674

    Google Scholar 

  26. Sagnella GA, Markandu ND, Shore AC, McGregor GA (1986) Raised circulating levels of atrial natriuretic peptides in essential hypertension. Lancet 1:179–183

    Google Scholar 

  27. Sawicki PT, Heinemann L, Rave K, Hohmann A, Berger M (1988) Atrial natriuretic factor in various stages of diabetic nephropathy. J Diabetes Complications 4:207–213

    Google Scholar 

  28. Saxenhofer H, Raselli A, Weidmann P, Forssmann WG, Bub A, Ferrari P, Schaw SG (1990) Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in men. Am J Physiol 259:F832-F838

    Google Scholar 

  29. Scherberich JE (1990) Urinary proteins of tubular origin: basic immunochemical and clinical aspects. Am J Nephrol 10 [Suppl 1]:43–51

    Google Scholar 

  30. Schifferdecker E, Keller A, Fröhlich A, Schmidt K, Böhm BO, Nickelsen T, Schumm-Draeger PM, Jungmann E, Althoff PH, Schöffling K (1990) Ambulante strukturierte 5-Tagesschulung: eine praktische Alternative. Aktuel Endokrinol Stoffwechsel 11:94

    Google Scholar 

  31. Schulz-Knappe P, Forssmann K, Herbst F, Hock KD, Pipkorn R, Forssmann WG (1988) Isolation and structural analysis of “urodilatin”, a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin Wochenschr 66:752–759

    Google Scholar 

  32. Sheffer Z, Peleg E, Salzberg M, Rosenthal T (1990) Atrial natriuretic peptide in diabetic patients before and after control of blood sugar level. Am J Hypertens 3:24A

    Google Scholar 

  33. Watts GF, Harris R, Shaw KM (1991) The determinants of early nephropathy in insulin-dependent diabetes mellitus a prospective study based on the urinary excretion of albumin. Quart J Med 79:365–378

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jungmann, E., Felber, A., Graeber, S. et al. Human atrial natriuretic peptide in patients with type 1 diabetes mellitus: is it related to the development of diabetic nephropathy?. Clin Investig 71, 604–609 (1993). https://doi.org/10.1007/BF00184483

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00184483

Key words

Navigation